ALPINE IMMUNE SCIENCES, INC. Total Liabilities and Equity
ALPINE IMMUNE SCIENCES, INC. had Total Liabilities and Equity of $373.65 million as of 2024-03-31, per its 10-Q filed 2024-05-09.
Discontinued › Balance Sheet
us-gaap:LiabilitiesAndStockholdersEquity · last filed 2024-05-09
- 2024-03-31: Liabilities and Equity $373.65M.
- 2023-12-31: Liabilities and Equity $379.85M.
- 2023-09-30: Liabilities and Equity $240.55M.
- 2023-06-30: Liabilities and Equity $252.84M.
| Period end | Liabilities and Equity | Liabilities and Equity as first filed |
|---|---|---|
| 2024-03-31 | $373.65M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $379.85M 10-Q · filed 2024-05-09 | |
| 2023-09-30 | $240.55M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $252.84M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $262.10M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $286.69M 10-K · filed 2024-03-20 | |
| 2022-09-30 | $291.60M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $215.83M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $233.94M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $255.90M 10-K · filed 2023-03-23 | |
| 2021-09-30 | $233.48M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $159.82M 10-Q · filed 2021-08-10 | |
| 2021-03-31 | $129.98M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $144.09M 10-K · filed 2022-03-17 | |
| 2020-09-30 | $154.03M 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $102.69M 10-Q · filed 2020-08-11 | |
| 2020-03-31 | $49.85M 10-Q · filed 2020-05-14 | |
| 2019-12-31 | $54.09M 10-K · filed 2021-03-18 | |
| 2019-09-30 | $64.74M 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $70.09M 10-Q · filed 2019-08-13 | |
| 2019-03-31 | $67.11M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $54.87M 10-K · filed 2020-03-30 | |
| 2018-09-30 | $64.51M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $73.12M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $80.70M 10-Q · filed 2018-05-14 | |
| 2017-12-31 | $85.22M 10-K · filed 2019-03-18 | |
| 2017-09-30 | $90.79M 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $49.64M 10-Q · filed 2017-07-21 | |
| 2017-03-31 | $53.01M 10-Q · filed 2017-05-02 | |
| 2016-12-31 | $12.60M 10-K · filed 2018-03-28 | $61.94M 10-K · filed 2017-02-13 |
| 2016-09-30 | $67.34M 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $74.56M 10-Q · filed 2016-08-02 | |
| 2016-03-31 | $80.94M 10-Q · filed 2016-05-03 | |
| 2015-12-31 | $87.91M 10-K · filed 2017-02-13 | |
| 2015-09-30 | $93.84M 10-Q · filed 2015-11-03 | |
| 2015-06-30 | $101.25M 10-Q · filed 2015-08-04 | |
| 2014-12-31 | $28.54M 10-K · filed 2016-03-08 |